|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 453.72 USD | -1.54% |
|
-8.98% | -0.26% |
| Capitalization | 12TCr 10TCr 9.11TCr 8.74TCr 16TCr 10,75800Cr 17TCr 1,07700Cr 43TCr 5,15900Cr 44TCr 43TCr 18,45100Cr | P/E ratio 2026 * |
26.3x | P/E ratio 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise value | 10TCr 8.85TCr 7.99TCr 7.67TCr 14TCr 9,43600Cr 15TCr 94TCr 38TCr 4,52500Cr 39TCr 38TCr 16,18400Cr | EV / Sales 2026 * |
7.88x | EV / Sales 2027 * | 6.83x |
| Free-Float |
99.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -1.53% | ||
| 1 week | -8.98% | ||
| Current month | -8.98% | ||
| 1 month | -5.38% | ||
| 3 months | +2.30% | ||
| 6 months | +14.41% | ||
| Current year | -0.26% |
| 1 week | 450.67 |  | 498.02 |
| 1 month | 450.67 | | 503.88 |
| Current year | 429 | | 503.88 |
| 1 year | 362.5 | | 519.68 |
| 3 years | 283.6 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 10/04/2019 |
Agam Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | -8.98% | -6.90% | +55.06% | 12TCr | |
| -0.42% | -6.94% | +7.25% | +206.93% | 88TCr | |
| -0.55% | -4.40% | +43.22% | +52.67% | 58TCr | |
| -1.45% | -1.50% | +8.47% | +47.22% | 41TCr | |
| -2.93% | -7.03% | +12.72% | +26.04% | 36TCr | |
| -1.85% | -6.70% | +20.55% | +34.98% | 30TCr | |
| -1.25% | -5.55% | +23.92% | +55.59% | 30TCr | |
| -1.09% | -7.53% | +21.81% | +3.06% | 29TCr | |
| -0.24% | -5.85% | +14.99% | +55.45% | 20TCr | |
| -0.87% | -3.32% | +24.10% | +77.54% | 18TCr | |
| Average | -1.22% | -1.73% | +17.01% | +61.45% | 36.17TCr | |
| Weighted average by Cap. | -1.08% | -1.72% | +18.16% | +83.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.3TCr 1.12TCr 1.01TCr 973.04Cr 1.77TCr 1,19700Cr 1.86TCr 12TCr 4.8TCr 57TCr 4.89TCr 4.79TCr 2,05400Cr | 1.43TCr 1.24TCr 1.12TCr 1.07TCr 1.95TCr 1,31800Cr 2.04TCr 13TCr 5.28TCr 63TCr 5.38TCr 5.27TCr 2,26000Cr |
| Net income | 449.57Cr 387.62Cr 349.91Cr 335.75Cr 612.23Cr 41TCr 640.73Cr 4.14TCr 1.66TCr 20TCr 1.69TCr 1.65TCr 71TCr | 512.29Cr 441.7Cr 398.73Cr 382.59Cr 697.65Cr 47TCr 730.12Cr 4.71TCr 1.89TCr 23TCr 1.92TCr 1.88TCr 81TCr |
| Net Debt | -1.44TCr -1.24TCr -1.12TCr -1.07TCr -1.96TCr -1,32200Cr -2.05TCr -13TCr -5.3TCr -63TCr -5.4TCr -5.28TCr -2,26700Cr | -1.91TCr -1.65TCr -1.49TCr -1.43TCr -2.6TCr -1,75800Cr -2.73TCr -18TCr -7.05TCr -84TCr -7.18TCr -7.03TCr -3,01500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 452.64 $ | -1.77% | 3,88,349 |
| 05/26/05 | 460.82 $ | -3.57% | 11,11,965 |
| 04/26/04 | 477.89 $ | +0.76% | 9,96,319 |
| 03/26/03 | 474.27 $ | -2.42% | 10,55,962 |
| 02/26/02 | 486.03 $ | -2.17% | 10,34,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition